Literature DB >> 23871663

Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.

Alberto Papi1, Marco Contoli, Ian M Adcock, Cinzia Bellettato, Anna Padovani, Paolo Casolari, Luminita A Stanciu, Peter J Barnes, Sebastian L Johnston, Kazuhiro Ito, Gaetano Caramori.   

Abstract

BACKGROUND: Although inhaled glucocorticoids are the mainstays of asthma treatment, they are poorly effective at treating and preventing virus-induced asthma exacerbations. The major viruses precipitating asthma exacerbations are rhinoviruses.
OBJECTIVE: We sought to evaluate whether rhinovirus infection interferes with the mechanisms of action of glucocorticoids.
METHODS: Cultured primary human bronchial or transformed (A549) respiratory epithelial cells were infected with rhinovirus 16 (RV-16) before dexamethasone exposure. Glucocorticoid receptor (GR) α nuclear translocation, glucocorticoid response element (GRE) binding, and transactivation/transrepression functional readouts were evaluated by using immunocytochemistry, Western blotting, DNA binding assays, real-time quantitative PCR, coimmunoprecipitation, and ELISA techniques. Specific inhibitors of c-Jun N-terminal kinase (JNK) and of IκB kinase (IKK) were used to investigate the involvement of intracellular signaling pathways.
RESULTS: RV-16 infection impaired dexamethasone-dependent (1) inhibition of IL-1β-induced CXCL8 release, (2) induction of mitogen-activated protein kinase phosphatase 1 gene expression, and (3) binding of GR to GREs in airway epithelial cells. This was associated with impaired GRα nuclear translocation, as assessed by means of both immunochemistry (54.0% ± 6.8% vs 24.7% ± 3.8% GR-positive nuclei after 10 nmol/L dexamethasone treatment in sham- or RV-16-infected cells, respectively; P < .01) and Western blotting. RV-16 infection induced nuclear factor κB activation and GRα phosphorylation, which were prevented by inhibitors of IKK2 and JNK, respectively. In rhinovirus-infected cells the combination of JNK and IKK2 inhibitors totally restored dexamethasone suppression of CXCL8 release, induction of mitogen-activated protein kinase phosphatase 1 gene expression, and GRα nuclear translocation.
CONCLUSION: RV-16 infection of human airway epithelium induces glucocorticoid resistance. Inhibition of RV-16-induced JNK and nuclear factor κB activation fully reversed rhinovirus impairment of both GRα nuclear translocation and the transactivation/transrepression activities of glucocorticoids.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Asthma; EC(50); Emax; GAPDH; GR; GRE; Glucocorticoid receptor; Glucocorticoid response element; Glyceraldehyde-3-phosphate dehydrogenase; HBEC; Human bronchial epithelial cell; ICAM-1; ICS; IKK; Inhaled corticosteroid; Intercellular adhesion molecule 1; IκB kinase; JNK; MKP-1; MOI; Maximal effective concentration; Median effective concentration; Mitogen-activated protein kinase phosphatase; Multiplicity of infection; NF-κB; Nuclear factor κB; RV-16; RV-1B; Rhinovirus 16; Rhinovirus type 1B; Small interfering RNA; c-Jun N-terminal kinase; glucocorticoids; kinases; siRNA; transcription factors; viral respiratory tract infections

Mesh:

Substances:

Year:  2013        PMID: 23871663     DOI: 10.1016/j.jaci.2013.05.028

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  26 in total

1.  The immunology of asthma.

Authors:  Bart N Lambrecht; Hamida Hammad
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

2.  A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19.

Authors:  Dallis Q Ngo; Kewan Hamid; Haris Rana; Maria Cardinale; Douglas Frenia; Nabil Ghani; Henry Redel
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-07-06       Impact factor: 2.585

3.  Advances in pediatric asthma in 2013: coordinating asthma care.

Authors:  Stanley J Szefler
Journal:  J Allergy Clin Immunol       Date:  2014-03       Impact factor: 10.793

4.  RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NFκB signaling.

Authors:  Kohei Hasegawa; Marcos Pérez-Losada; Claire E Hoptay; Samuel Epstein; Jonathan M Mansbach; Stephen J Teach; Pedro A Piedra; Carlos A Camargo; Robert J Freishtat
Journal:  Pediatr Res       Date:  2018-01-17       Impact factor: 3.756

5.  IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers.

Authors:  Michelle L Hernandez; Katherine Mills; Martha Almond; Krista Todoric; Maria M Aleman; Hongtao Zhang; Haibo Zhou; David B Peden
Journal:  J Allergy Clin Immunol       Date:  2014-09-05       Impact factor: 10.793

Review 6.  Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?

Authors:  Tomoshige Kino; Irina Burd; James H Segars
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

7.  Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist.

Authors:  Javier Milara; Anselm Morell; Bea Ballester; Celia Sanz; Jose Freire; Xiaozhong Qian; Maggie Alonso-Garcia; Esteban Morcillo; Julio Cortijo
Journal:  Respir Res       Date:  2015-02-05

8.  Effect of lipopolysaccharide on glucocorticoid receptor function in control nasal mucosa fibroblasts and in fibroblasts from patients with chronic rhinosinusitis with nasal polyps and asthma.

Authors:  Laura Fernández-Bertolín; Joaquim Mullol; Mireya Fuentes-Prado; Jordi Roca-Ferrer; Isam Alobid; César Picado; Laura Pujols
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

9.  Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin.

Authors:  Md Mostafizur Rahman; Nowshin N Rumzhum; Jonathan C Morris; Andrew R Clark; Nicole M Verrills; Alaina J Ammit
Journal:  Sci Rep       Date:  2015-05-18       Impact factor: 4.379

10.  Functional and genetic predisposition to rhinovirus lower respiratory tract infections in prematurely born infants.

Authors:  Simon B Drysdale; Mireia Alcazar; Theresa Wilson; Melvyn Smith; Mark Zuckerman; Hennie M Hodemaekers; Riny Janssen; Louis Bont; Sebastian L Johnston; Anne Greenough
Journal:  Eur J Pediatr       Date:  2016-10-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.